These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 8941934

  • 1. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.
    Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
    [Abstract] [Full Text] [Related]

  • 2. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension.
    Jover B, Herizi A, Casellas D, Mimran A.
    J Hypertens; 2001 Nov; 19(11):2039-46. PubMed ID: 11677370
    [Abstract] [Full Text] [Related]

  • 3. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
    Perico N, Remuzzi A, Sangalli F, Azzollini N, Mister M, Ruggenenti P, Remuzzi G.
    J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785
    [Abstract] [Full Text] [Related]

  • 4. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M, Fukuda R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y.
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of enalapril and irbesartan in experimental papillary necrosis.
    Garber SL, Mirochnik Y, Arruda JA, Dunea G, Slobodskoy L.
    Kidney Blood Press Res; 2001 Dec; 24(1):39-43. PubMed ID: 11174005
    [Abstract] [Full Text] [Related]

  • 6. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H, Suzuki H, Kanno Y, Ikenaga H, Saruta T.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T, Inada Y, Ojima M, Sanada T, Shibouta Y, Nishikawa K.
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
    Lafayette RA, Mayer G, Park SK, Meyer TW.
    J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
    [Abstract] [Full Text] [Related]

  • 9. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 10. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
    Kanagawa R, Wada T, Sanada T, Ojima M, Inada Y.
    Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, Nisato D.
    Eur J Pharmacol; 1994 Nov 03; 264(3):307-16. PubMed ID: 7698170
    [Abstract] [Full Text] [Related]

  • 15. Effects of candesartan cilexetil on oxidative state and renal function in 5/6 nephrectomized rats.
    Sugimoto K, Tsuruoka S, Matsushita K, Fujimura A.
    J Hum Hypertens; 1999 Jan 03; 13 Suppl 1():S63-70; discussion S81. PubMed ID: 10076923
    [Abstract] [Full Text] [Related]

  • 16. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
    Intengan HD, Thibault G, Li JS, Schiffrin EL.
    Circulation; 1999 Nov 30; 100(22):2267-75. PubMed ID: 10578002
    [Abstract] [Full Text] [Related]

  • 17. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
    Noda M, Matsuo T, Fukuda R, Ohta M, Nagano H, Shibouta Y, Naka T, Nishikawa K, Imura Y.
    Kidney Int; 1999 Sep 30; 56(3):898-909. PubMed ID: 10469358
    [Abstract] [Full Text] [Related]

  • 18. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
    Kvam FI, Ofstad J, Iversen BM.
    Am J Physiol; 1998 Oct 30; 275(4):F576-84. PubMed ID: 9755129
    [Abstract] [Full Text] [Related]

  • 19. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A, Zoja C, Zatelli C, Corna D, Longaretti L, Rottoli D, Maggioni P, Todeschini M, Noris M, Remuzzi G.
    Kidney Int; 2004 Nov 30; 66(5):1959-65. PubMed ID: 15496167
    [Abstract] [Full Text] [Related]

  • 20. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
    Dukacz SA, Kline RL.
    J Hypertens; 1999 Sep 30; 17(9):1345-52. PubMed ID: 10489114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.